60 Degrees Pharma (SXTP) Rockets 11.5% as Tropical Disease R&D Gains Traction
60 Degrees Pharma surges 11.49% as investors chase its tropical disease pipeline—new regulatory milestones and partnerships could boost the small‑cap biotech’s long‑term upside.
- 60 DEGREES PHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read